The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...
Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm: CANTA) today announced that Damian Marron, Interim CEO, will participate ...
Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours ...
Fintel reports that on March 11, 2025, HC Wainwright & Co. initiated coverage of Westwater Resources (NYSEAM:WWR) with a Buy ...
H.C. Wainwright lowered the firm’s price target on Zynex (ZYXI) to $15 from $17 and keeps a Buy rating on the shares. The company reported a ...
Investment analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Cidara Therapeutics in a report issued on Monday, March 10th. HC Wainwright analyst E. Arce anticipates that the ...
H.C. Wainwright raised the firm’s price target on Endeavour Silver (EXK) to $7.25 from $7 and keeps a Buy rating on the shares following the ...
Investment analysts at HC Wainwright lowered their Q1 2025 EPS estimates for EyePoint Pharmaceuticals in a research note ...
Analyst initiates coverage of WWR with Buy rating and $2.50 PT. Westwater aims to create self-sustained graphite supply chain ...
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...
Fintel reports that on March 6, 2025, HC Wainwright & Co. initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation. As of March 4, 2025, the average one-year price target for ...
Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...